Literature DB >> 3887066

The use of microorganisms for the study of drug metabolism.

A M Clark, J D McChesney, C D Hufford.   

Abstract

The potential for the use of microorganisms as tools in the study of drug metabolism appears to be unlimited. The selected examples cited here are only the beginning of what could develop into a widely accepted alternative in vitro model system for studying drug metabolism in humans. As with any other in vitro model system, it is not expected that microbial systems could ever replace animals in biomedical research. The acquisition of data regarding absorption, distribution, and excretion will still require whole animal systems. However, it is clear from the examples cited that microbial systems offer a reliable, reproducible alternative to small animal models for preliminary drug metabolism studies. Due to significant species variation, small animal models may, in many cases, be less reliable than microorganisms as predictive models of human metabolism. It has been estimated that approximately 70 million animals are used each year in the U.S. for biomedical research. The development of any techniques which curtail the sacrifice of such large numbers of animals is welcomed both by animal welfare groups who wish to ensure the humane treatment of laboratory animals and by researchers who additionally appreciate the more practical and economical benefits of such alternatives.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887066     DOI: 10.1002/med.2610050203

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  12 in total

1.  Microbial production of a crisnatol metabolite.

Authors:  C D Hufford; S H el-Sharkawy; T M Jurgens; J R Mikell
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

2.  The metabolism of CGP-291: the use of microorganisms as models of mammalian metabolism.

Authors:  T M Jürgens; A M Clark
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

3.  Microbial metabolism studies of the antimalarial drug arteether.

Authors:  I S Lee; H N ElSohly; C D Hufford
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

4.  Microbial metabolism of the beta-adrenoreceptor antagonist bisoprolol.

Authors:  H Schwartz; R E Licht; H E Radunz
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

5.  Microbial oxidation of ebastine.

Authors:  H Schwartz; A Liebig-Weber; H Hochstätter; H Böttcher
Journal:  Appl Microbiol Biotechnol       Date:  1996-02       Impact factor: 4.813

6.  Microbial models of mammalian metabolism: stereoselective metabolism of warfarin in the fungus Cunninghamella elegans.

Authors:  Y W Wong; P J Davis
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

7.  Microbial and mammalian metabolism studies on the semisynthetic antimalarial, deoxoartemisinin.

Authors:  S I Khalifa; J K Baker; M Jung; J D McChesney; C D Hufford
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

8.  Microbial and mammalian metabolism studies of the semisynthetic antimalarial, anhydrodihydroartemisinin.

Authors:  S I Khalifa; J K Baker; R D Rogers; F S el-Feraly; C D Hufford
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  The screening of selected microorganisms for use as models of mammalian drug metabolism.

Authors:  D A Griffiths; D J Best; S G Jezequel
Journal:  Appl Microbiol Biotechnol       Date:  1991-06       Impact factor: 4.813

10.  Fungal metabolism of 4-methylprimaquine.

Authors:  A M Clark; J D McChesney; C D Hufford
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.